Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of FDA Orange Book Patents covering Ranolazine

Client Email

Product

Ranolazine
CAS 2210-74-4
CAS 5294-61-1
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Ranolazine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

56 API Suppliers, 28 USDMF, 16 EU WC, 1 KDMF, 22 NDC API, 39 Listed Suppliers, $ API Reference Price

56 API Suppliers
28 USDMF
16 EU WC
1 KDMF
22 NDC API
39 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Imports

INTERMEDIATES

16 API Suppliers

16 API Suppliers

FINISHED DOSAGE FORMULATIONS

109 FDF Dossiers, 54 FDA Orange Book, 28 Europe, 2 Canada, 3 South Africa, 22 Listed Dossiers

109 FDF Dossiers
54 FDA Orange Book
28 Europe
2 Canada
3 South Africa
22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GRANULES, EXTENDED RELEASE;ORAL - 1GM, GRANULES, EXTENDED RELEASE;ORAL - 500MG

TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GRANULES, EXTENDED RELEASE;ORAL - 1GM
GRANULES, EXTENDED RELEASE;ORAL - 500MG

RELATED EXCIPIENT COMPANIES

1 Evonik, 1 SPI Pharma, 2 DKSH, 1 Jai Radhe Sales, 8 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 1 Clariant, 13 Corel Pharma Chem, 4 DFE Pharma, 10 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Nanjing Bold Chemical, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

62 Coating Systems & Additives, 44 Fillers, Diluents & Binders, 32 Controlled & Modified Release, 20 Direct Compression, 14 Solubilizers, 14 Thickeners and Stabilizers, 13 Lubricants & Glidants, 12 Film Formers & Plasticizers, 12 Co-Processed Excipients, 10 Granulation, 9 Parenteral, 7 Disintegrants & Superdisintegrants, 7 Topical, 6 Taste Masking, 5 Empty Capsules, 5 API Stability Enhancers, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 Coloring Agents, 4 Rheology Modifiers, 3 Surfactant & Foaming Agents, 3 Chewable & Orodispersible Aids

62 Coating Systems & Additives
44 Fillers, Diluents & Binders
32 Controlled & Modified Release
20 Direct Compression
14 Solubilizers
14 Thickeners and Stabilizers
13 Lubricants & Glidants
12 Film Formers & Plasticizers
12 Co-Processed Excipients
10 Granulation
9 Parenteral
7 Disintegrants & Superdisintegrants
7 Topical
6 Taste Masking
5 Empty Capsules
5 API Stability Enhancers
5 Emulsifying Agents
4 Vegetarian Capsules
4 Coloring Agents
4 Rheology Modifiers
3 Surfactant & Foaming Agents
3 Chewable & Orodispersible Aids

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 25 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
25 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 25 Finished Drug Prices, 8 Annual Reports

1 US Medicaid Prescriptions
25 Finished Drug Prices
8 Annual Reports

MARKET PLACE

17 APIs, 2 FDF Dossiers

17 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents

3 US Patents

REF. STANDARDS & IMPURITIES

4 USP, 9 Others

4 USP
9 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 84 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

3 All

01 3SPIL

filter Patent Number Reset all filters

3 All

01 110898444

02 211510878

filter API Patent Reset all filters

3 All

01 3Blank

filter FDF Patent Reset all filters

3 All

01 3Y

filter Expiration Date Reset all filters

3 All

01 32038-01-24

DRL Ranolazine Popup

Product Main Page

01

SPIL

Formnext Forum

Not Confirmed

SPIL

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-01-24

US Patent Number : 11510878

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216018

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-01-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

SPIL

Formnext Forum

Not Confirmed

SPIL

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-01-24

US Patent Number : 10898444

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216018

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-01-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

SPIL

Formnext Forum

Not Confirmed

SPIL

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-01-24

US Patent Number : 11510878

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216018

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-01-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?